Dark

MBRX
Moleculin Biotech, Inc.
stock NASDAQ

Market Open

Jun 13, 2025 1:02:03 PM EDT

0.6500USD-2.034%(-0.0136)276,263

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jun 13, 2025 9:25:30 AM EDT

0.6669USD-0.239%(-0.0016)6,674

After-hours

Jun 12, 2025 4:14:30 PM EDT

0.6700USD+2.290%(+0.0150)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

9.09M

Headquarters

Houston, Texas, USA

Industry

Biotechnology

Last Split

Mar 22, 20241for15reverse

OMER XLV

MBRX Stats

Avg. Vol. 10 Day

1,662,549

Avg. Vol. 30 Day

783,328

Market Cap

9,086,804

Shares Out.

14,127,494

On/Off Exchange

38%/62%

6 Month Beta

1.33

1 Year Beta

1.12

2 Year Beta

1.01

3 Year Beta

0.77

52 Week Low

0.40

52 Week High

4.90

SMA50

0.90

SMA200

1.72

1 Week

-4.00%

1 Month

-39.89%

3 Month

-44.55%

6 Month

-72.28%

1 Year

-85.21%

2 Year

-93.14%

5 Year

-99.36%

Profile

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. the other portfolio targets the metabolism of tumors.

MBRX Stock Summary

Moleculin Biotech, Inc. (NASDAQ:MBRX) stock price today is $0.6500, and today's volume is 276,263. MBRX is down -2.034% today. The 30 day average volume is 783,328. MBRX market cap is 9.09M with 14,127,494 shares outstanding.